Industry-chain Research Brief

Nanjing HeBen M&E Equipment Technology Co., Ltd.: Biomedicine and medical devices Little Giant Industry Chain Brief

Jiangsu · Biomedicine and medical devices · 2026-06-14

English company profile Full Chinese report All report summaries

English Summary

Nanjing HeBen M&E Equipment Technology Co., Ltd. is a China Little Giant company report summary for overseas readers. The company is associated with Jiangsu. The report is indexed under Biomedicine and medical devices. The Chinese report was published on 2026-06-14. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.

Report Snapshot

CompanyNanjing HeBen M&E Equipment Technology Co., Ltd.
RegionJiangsu
IndustryBiomedicine and medical devices
Published2026-06-14
Chinese reportOpen
CompanyNanjing HeBen M&E Equipment Technology Co., Ltd.
Region / IndustryJiangsu · Biomedicine and medical devices
Recognition2024 6th batch
Patent signal88 patent-related records

Company and Recognition Snapshot

Nanjing HeBen M&E Equipment Technology Co., Ltd. is indexed as a national-level Little Giant enterprise in Jiangsu. The English profile places the company under Biomedicine and medical devices and records 2024 6th batch as the available recognition context.

Recognition batch2024 6th batch
RegionJiangsu
IndustryBiomedicine and medical devices
Registered capitalRMB 21.61 million
Employee signal303 employees
Listed statusNot listed
Patent signal88 patent-related records
R&D signalR&D investment detail not published in the English dataset

Business and Industry-chain Position

Chinese public records indicate software, systems and digital-technology activity, R&D, design and engineering activity. The recorded industry-chain position is High-end equipment and industrial automation / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.

Technology, Patent and R&D Signals

The public profile records 88 patent-related records. The R&D signal is: R&D investment detail not published in the English dataset. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.

Policy-material Review Points

  • Verify whether the company's main business, niche market and product evidence all point to Biomedicine and medical devices.
  • Check that patent, R&D, employee and financial fields support the same core product direction.
  • Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
  • Use the linked Chinese source report for original-language evidence and source links.

Original Report and Profile

For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.

Related Search Paths